This invention provides a
leucine dehydrogenase mutant, a
valine-producing strain comprising this
leucine dehydrogenase mutant, and its applications. The invention designs a
leucine dehydrogenase mutant with the following mutations:
tyrosine (Tyr) at position 48 is mutated to
serine (Ser),
histidine (His) at position 127 is mutated to
arginine (Arg),
tyrosine (Tyr) at position 186 is mutated to
phenylalanine (Phe),
isoleucine (Ile) at position 256 is mutated to
valine (Val), and
lysine (Lys) at position 308 is mutated to
arginine (Arg). These mutations are used to construct a
valine-producing strain. The new strain is
plasmid-free, has no growth defects, requires no induction, and exhibits advantages such as good
genetic stability and high
fermentation yield. It is an excellent strain capable of stably producing valine. This strain efficiently synthesizes valine de novo using glucose as a substrate, significantly increasing valine yield.